Company · CIK 0001386570 · SIC 2833 — Medicinal Chemicals & Botanical Products · Nasdaq
Niagen Bioscience, Inc. · NAGE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 AForm 4 → | Jul 8, 5:18 pm EDT | Carlos Luis LopezSVP, General Counsel | 2,314 | $2.71 | $6,271 | 4,565 | — | late |
| Jun 30, 2026 AForm 4 → | Jul 8, 5:17 pm EDT | Ozan PamirChief Financial Officer | 4,255 | $2.71 | $11,531 | 11,627 | — | late |
| Jun 30, 2026 AForm 4 → | Jul 8, 5:16 pm EDT | Robert N FriedChief Executive Officer, Director | 1,106 | $2.71 | $2,997 | 1,060,087 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.